T

Tiziana Life Sciences Ltd
D

TLSA

1.76800
USD
0.05
(2.61%)
مغلق
حجم التداول
9,998
الربح لكل سهم
-0
العائد الربحي
-
P/E
-15
حجم السوق
210,080,844
أصول ذات صلة الأخبار المقالات

العنوان: Tiziana Life Sciences Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.